Fibbi G, Ziche M, Morbidelli L, Magnelli L, Del Rosso M
Department of Preclinical and Clinical Pharmacology, Mario Aiazzi Mancini, Firenze, Italy.
Exp Cell Res. 1988 Dec;179(2):385-95. doi: 10.1016/0014-4827(88)90277-7.
On the basis of 125I-labeled plasminogen activator binding analysis we have found that bovine adrenal capillary endothelial cells have specific receptors for human urinary-type plasminogen activator on the cell membrane. Each cell exposes about 37,000 free receptors with a Kd of 0.8958 x 10(-9) M [corrected]. A monoclonal antibody against the 17,500 proteolytic fragment of the A chain of the plasminogen activator, not containing the catalytic site of the enzyme, impaired the specific binding, thus suggesting the involvement of a sequence present on the A chain in the interaction with the receptor, as previously shown in other cell model systems. Both the native molecule and the A chain are able to stimulate endothelial cell motility in the Boyden chamber, when used at nanomolar concentrations. The use of the same monoclonal antibody that can inhibit ligand-receptor interaction can impair the plasminogen activator and A-chain-induced endothelial cell motility, suggesting that under the conditions used in this in vitro model system, the motility of bovine adrenal capillary endothelial cells depends on the specific interaction of the ligand with free receptors on the surface of endothelial cells.
基于¹²⁵I标记的纤溶酶原激活物结合分析,我们发现牛肾上腺毛细血管内皮细胞在细胞膜上具有人尿激酶型纤溶酶原激活物的特异性受体。每个细胞约有37,000个游离受体,解离常数(Kd)为0.8958×10⁻⁹M[已校正]。一种针对纤溶酶原激活物A链17,500蛋白水解片段的单克隆抗体,该片段不包含酶的催化位点,可损害特异性结合,因此表明A链上存在的一个序列参与了与受体的相互作用,正如先前在其他细胞模型系统中所显示的那样。当以纳摩尔浓度使用时,天然分子和A链均能够在博伊登小室中刺激内皮细胞迁移。使用能够抑制配体-受体相互作用的相同单克隆抗体,可损害纤溶酶原激活物和A链诱导的内皮细胞迁移,这表明在该体外模型系统所使用的条件下,牛肾上腺毛细血管内皮细胞的迁移取决于配体与内皮细胞表面游离受体的特异性相互作用。